Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Marco Angelo Colleoni
Based on 90 articles published since 2008
||||
Expertise Level
The expertise of Marco Angelo Colleoni ranks in the
  • Top 0.022%
  • ... of 263,330 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 90 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Colleoni, Marco   ·   Colleoni, Marco Angelo
Work Locations
Details
Most likely:    European Institute of Oncology      
2018
  • Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: · IBCSG Statistical Center and Department of Mathematics and Statistics, University of Vermont, Burlington, VT, USA. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy. · Centro di Riferimento Oncologico, Aviano, Italy. · Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Orsola Hospital and University of Bologna, Bologna, Italy. · Riverina Cancer Care Centre, Wagga Wagga, NSW, Australia. · Breast Center St Gallen, Kantonsspital, St Gallen, Switzerland. · Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · IBCSG and University of Sydney, Sydney, NSW, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · IBCSG and European Institute of Oncology, Milan, Italy. · Pubmed 30196031
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Seoul National University Hospital, Cancer Research Institute, and Seoul National University College of Medicine, Seoul, South Korea. · Division of Medical Senology, Istituto Europeo di Oncologia, Milan, Italy. · Hospital de Caridade de Ijuí, Cacon, Ijuí, Brazil. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Breast Center, Department of Obstetrics and Gynaecology, University of Munich, Munich, Germany. · UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Organisation for Oncology and Translational Research, Hong Kong Special Administrative Region, China. · Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea. · Research Institute and Hospital, National Cancer Center, Goyang, South Korea. · Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico. · Institut Català d'Oncologia, Hospital Moisès Broggi, Barcelona, Spain. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · HCG Curie Centre of Oncology and Kidwai Memorial Institute of Oncology, Bangalore, India. · University of Ottawa, Ottawa, ON, Canada. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Breast Unit, Kliniken Essen-Mitte, Essen, Germany. · American University of Beirut Medical Center, Beirut, Lebanon. · Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan. · Novartis, East Hanover, NJ, USA. · Novartis, Basel, Switzerland. · National Taiwan University Hospital, Taipei, Taiwan. Electronic address: · Pubmed 29804902
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, and Harvard T.H Chan School of Public Health, Boston, MA, USA. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, Department of Oncology and Hemato-oncology, European Institute of Oncology and University of Milan, Milan, Italy. · National Institute of Oncology, Budapest, Hungary. · Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Rimini, Dipartimento di Oncologia ed Ematologia, AUSL della Romagna, Rimini, Italy. · Translational Research Coordination and Central Pathology Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan and International Breast Cancer Study Group Central Pathology Office, Milan, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, and International Breast Cancer Study Group, Prato, Italy. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School and Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Scientific & Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, and International Breast Cancer Study Group, Milan, Italy. · Pubmed 29589138
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy. · Data Management, Clinical Trial Office, Scientific Direction, European Institute of Oncology, Milan, Italy. · Scientific and Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Pubmed 29486983
  • Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. Electronic address: · IRCCS Arcispedale S Maria Nuova Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Italy. · European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy. · SSD Medical Oncology Addari, Policlinico Sant'Orsola Malpighi, Bologna, Italy. · Department of Oncology, Azienda Sanitaria Universitaria Integrata, Udine, Italy. · Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. · Oncology, Azienda Ospedaliero Universitaria di Ferrara-Arcispedale Sant'Anna, Ferrara, Italy. · Fondazione Michelangelo, Milan, Italy. · Pubmed 29326029
  • International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia. · International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland. · International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium. · International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. · International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary. · International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium. · International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy. · Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark. · Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · German Breast Group, Neu-Isenburg, Germany. · SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain. · Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. · Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria. · Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile. · Cancer Trials Ireland and Cork University Hospital, Cork, Ireland. · International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy. · Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium. · Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland. · Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy. · International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy. · Pubmed 29158011
  • Post-graduation school in Radiodiagnostics, University of Milan, Milan, Italy. · Department of Radiological Science and Radiation Therapy, European Institute of Oncology (IEO), Milan, Italy. · Division of Medical Senology, European Institute of Oncology (IEO), Milan, Italy. · Department of Oncology, University of Milan, Milan, Italy. · Pubmed 30312335
  • Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Radiotherapy, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Plastic and Reconstructive Surgery, IRCCS Policlinico San Donato, piazza Edmondo Malan 1, San Donato Milanese, 20097, Milan, Italy. · Pubmed 29759643
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Pathology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Endoscopy, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 28778379
2017
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 28093280
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Biobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Biobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy; University of Milan, School of Medicine, Italy. Electronic address: · Pubmed 28544923
  • Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School · Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute · Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation · Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation · Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA · Signe Borgquist, Lund University, Lund, Sweden · Thomas P. Ahern, University of Vermont, Burlington, VT · Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy · István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary · Marc Debled, Institut Bergonié, Bordeaux, France · Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark · Roger von Moos, Cantonal Hospital Graubuenden, Chur · Swiss Group for Clinical Cancer Research and IBCSG · Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern · Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen · Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland · Ian Smith, The Royal Marsden Hospital, London, United Kingdom · and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia. · Pubmed 28380313
  • Division of Medical Senology, European Institute of Oncology, 20141 Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, 20141 Milan, Italy. · Division of Early Drugs Development, European Institute of Oncology, 20141 Milan, Italy. · Palliative Care, Sassari, Italy. · Department of Medicine, European Institute of Oncology, 20141 Milan, Italy. · Division of Medical Senology, European Institute of Oncology, 20141 Milan, Italy. Electronic address: · Pubmed 28131905
  • Poornima Saha and Gini F. Fleming, The University of Chicago Medical Center, Chicago, IL · Meredith M. Regan, Weixiu Luo, Harold J. Burstein, and Richard D. Gelber, Dana-Farber Cancer Institute · Meredith M. Regan, Harold J. Burstein, and Richard D. Gelber, Harvard Medical School · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA · Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello · Karin Ribi and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center · Jürg Bernhard, Bern University Hospital, Inselspital, Bern, Switzerland · Prudence A. Francis, Peter MacCallum Cancer Center · St Vincent's Hospital · University of Melbourne, Melbourne · Josephine Stewart, Austin and Heidelberg Repatriation Medical Center, Heidelberg, Victoria · Prudence A. Francis, Josephine Stewart, and Michelle Nottage, University of Newcastle, Newcastle · Alan S. Coates, University of Sydney, Sydney, New South Wales · Michelle Nottage, Royal Brisbane Hospital, Brisbane, Queensland, Australia · Barbara A. Walley, University of Calgary · National Cancer Institute of Canada, Calgary, Alberta, Canada · Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru · Vani Parmar, Tata Memorial Centre, Mumbai, India · Roberto Torres, Instituto Nacional del Cancer, Santiago de Chile, Chile · Meritxell Bellet, Vall d'Hebron Institute of Oncology · Vall d'Hebron University Hospital · Universitat Autònoma de Barcelona, Barcelona · Antonia Perelló, Hospital Universitari Son Espases, Palma de Mallorca, Spain · Faysal Dane, Marmara University Hospital, Istanbul, Turkey · Antonio Moreira, Instituto Português de Oncologia Francisco Gentil - Centro de Lisboa, Lisbon, Portugal · Daniel Vorobiof, Sandton Oncology Centre, Johannesburg, South Africa · and Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy. · Pubmed 28654365
  • Department of Surgery and Cancer, Imperial College London, London, UK. · Department of Experimental Oncology, European Institute of Oncology Milan, Italy. · Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, IT. · Swammerdam Institute for Life Sciences, University of Amsterdam. · Genomics Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, USA. · Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), Italy. · Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), and Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany. · Division of Pathology, European Institute of Oncology and University of Milan, School of Medicine, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milano, Milan, IT. · Division of Medical Senology, European Institute of Oncology, IEO, Milan, Italy. · Department of Biosciences, University of Milano, Milan, IT. · Pubmed 28112739
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Pubmed 27810700
2016
  • IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA. · Harvard T. H. Chan School of Public Health, Boston, MA, USA. · IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary. · Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 27372069
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Jacquie H. Chirgwin and John F. Forbes, University of Newcastle · John F. Forbes, Calvary Mater Newcastle, Newcastle · Alan S. Coates, University of Sydney School of Public Health, Sydney, New South Wales · Jacquie H. Chirgwin, Box Hill Hospital · Jacquie H. Chirgwin, Maroondah Hospital · Jacquie H. Chirgwin, Monash University, Melbourne, Victoria, Australia · Anita Giobbie-Hurder, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard Medical School, Boston, MA · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergonié, Bordeaux, France · Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy · Ian Smith, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom · Manuela Rabaglio, Inselspital, Bern · Beat Thürlimann, Kantonsspital, St. Gallen, Switzerland · Patrick Neven, University of Leuven · Patrick Neven, University Hospitals Leuven, Leuven, Belgium · István Láng, National Institute of Oncology, Budapest, Hungary. · Pubmed 27217455
  • Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, IL, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4, Dnipropetrovsk, Ukraine. · National Cancer Center, Goyang-si, South Korea. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · NHO Osaka National Hospital, Osaka, Japan. · Istituto Europeo di Oncologia, Milan, Italy. · Center for Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München (LMU), Munich, Germany. · Pfizer, San Diego, CA, USA. · Pfizer, Cambridge, MA, USA. · Pfizer, Collegeville, PA, USA. · Pfizer, New York, NY, USA. · University of California, Los Angeles, Los Angeles, CA, USA. · Pubmed 26947331
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Avenue, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Swiss Group for Clinical Cancer Research SAKK, Lugano Viganello, Switzerland. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Via Ripamonti 435, Milan, 20141, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · IBCSG Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Dana-Farber Cancer Institute, Department of Biostatistics and Computatonal Biology, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, 450 Brookline Avenue, Boston, MA, 02215, USA. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · National Cancer Institute of Canada, Kingston, ON, Canada. · Pubmed 27825388
  • Department of Oncology, Institute of Clinical Sciences, Sahgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: · Department of Mathematics and Statistics, University of Vermont, Burlington, Vermont. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, Massachusetts. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Harvard T. F. Chan School of Public Health, Boston, Massachusetts. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · Senior Consultant Breast Cancer, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · International Breast Cancer Study Group, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Institute of Radiotherapy, Klinik Hirslanden, Zürich, Switzerland. · Pubmed 27598802
  • Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA · Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne · University of Newcastle, Newcastle · Alan S. Coates, University of Sydney, Sydney, Australia · Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland · Gini F. Fleming, University of Chicago Medical Center, Chicago, IL · Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada · Giuseppe Viale, University of Milan · Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan · Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo · Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy · István Láng, National Institute of Oncology, Budapest, Hungary · Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Pubmed 27044936
  • Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan 20141, Italy. Electronic address: · Pubmed 26869050
  • Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Radiotherapy, European Institute of Oncology, Milan, Italy. · Department of Surgery, European Institute of Oncology, Milan, Italy. · Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26842491
  • Marco Colleoni and Aron Goldhirsch, European Institute of Oncology and International Breast Cancer Study Group, Milan · Lorenzo Gianni, Ospedale degli Infermi and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy · Zhuoxin Sun, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center and Frontier Science and Technology Research Foundation · Zhuoxin Sun and Richard D. Gelber, Harvard T.F. Chan School of Public Health · Richard D. Gelber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Per Karlsson, Institute of Selected Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden · John F. Forbes, Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Beat Thürlimann, Breast Center Kantonsspital, St Gallen, and Swiss Group for Clinical Cancer Research · and Monica Castiglione, International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 26786933
2015
  • Division of Medical Senology and International Breast Cancer Study Group, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 26241939
  • Division of Medical Senology, and International Breast Cancer Study Group, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy, · Pubmed 26177891
  • International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Dana-Farber Cancer Institute and Alliance for Clinical Trials in Oncology, Boston, MA, USA. · Medical Oncology, Osp Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo, Italy. · Medical Oncology, Ospedale di Circolo and Fondazione Macchi, and International Breast Cancer Study Group, Varese, Italy. · Medical Oncology, Centro di Riferimento Oncologico, and International Breast Cancer Study Group, Aviano, Italy. · Breast Center, Kantonsspital St Gallen, Swiss Group for Clinical Cancer Research (SAKK), and International Breast Cancer Study Group, St Gallen, Switzerland. · Department of Oncology, University Hospital of Udine, University of Udine and International Breast Cancer Study Group, Udine, Italy. · Oncology Unit, Salvatore Maugeri Foundation, and International Breast Cancer Study Group, Pavia, Italy. · Surgical Oncology, Breast Services, Tata Memorial Hospital, and International Breast Cancer Study Group, Mumbai, India. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, Lugano Viganello, Switzerland. · University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne and Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia, and International Breast Cancer Study Group. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Program for Breast Health (Senology), European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland. · Tom Baker Cancer Centre and National Cancer Institute of Canada Clinical Trials Group, Calgary, AB, Canada. · Pubmed 26092816
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, and Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · University of Milan School of Medicine, Milan, Italy; Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 25933934
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26362840
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Quantitative Methods and Statistics, University of Milan-Bicocca, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 26255932
  • Division of Medical Senology, European Institute of Oncology, Italy; International Breast Cancer Study Group, Italy. Electronic address: · Division of Medical Senology, European Institute of Oncology, Italy. · Pubmed 26249119
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Karen N. Price, Frontier Science and Technology Research, Boston, MA · Elizabeth Mallon, Southern General Hospital · Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom · Giuseppe Viale, European Institute of Oncology and University of Milan · Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy · Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergoniié, Bordeaux, France · and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
2014
  • International Breast Cancer Study Group; European Institute of Oncology, Milan, Italy. · Pubmed 24516011
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 24998489
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Scientific Direction, European Institute of Oncology, Milan, Italy. · Pubmed 24742826
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. Electronic address: · Pubmed 24709436
  • International Breast Cancer Study Group and Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. Electronic address: · International Breast Cancer Study Group and Breast Health Program, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 24360786
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, Unit of Biostatistics, Epidemiology and Public Health, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Italy. · School of Medicine, University of Milan, Italy; Molecular Senology Unit, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Vice-Scientific Director, European Institute of Oncology, Milan, Italy. · Pubmed 24325948
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Italy. · Integrated Breast Surgery Unit, European Institute of Oncology and University of Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 24183613
2013
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24074780
  • Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. Electronic address: · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA. · Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Department of Medical and Biological Sciences, Medical Oncology, University of Udine, Udine, Italy. · Quality of Life Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Institute of Oncology, Budapest, Hungary. · Department of Oncology, Ospedale Infermi Rimini and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy. · Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. · Medical Oncology, Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Medical Oncology, Spital STS AG, Thun, Switzerland. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Unité de Onco-Gynécologie médicale, Departement de Médecine Hôpitaux, Universitaires de Genève, Genève, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Department of Medical Oncology, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23453899
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 23633450
2011
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22015285
  • European Institute of Oncology, Milan, Italy. · Pubmed 21321298
2018
  • From the Institute of Cancer Research and Royal Marsden Hospital, London (N.C.T.) · David Geffen School of Medicine at University of California, Los Angeles, Santa Monica (D.J.S.), and Pfizer Oncology, San Diego (X.H.) - both in California · National Cancer Center, Goyang-si, Gyeonggi-do (J.R.), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul (S.-A.I.) - both in South Korea · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital 4, Dnipropetrovsk, Ukraine (I.B.) · National Hospital Organization Osaka National Hospital, Osaka (N.M.), and Aichi Cancer Center Hospital, Nagoya (H.I.) - both in Japan · Istituto Europeo di Oncologia (M. Colleoni) and Pfizer Oncology (C.G.) - both in Milan · Abramson Cancer Center, University of Pennsylvania, Philadelphia (A.D.), and Pfizer Oncology, Collegeville (C.H.B.) - both in Pennsylvania · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi) · Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada (S.V.) · Brustzentrum der Universität München, Munich (N.H.), and the German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany · Institut Gustave Roussy, Villejuif, France (F.A.) · Pfizer Oncology, Cambridge, MA (K.P.T.) · and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago (M. Cristofanilli). · Pubmed 30345905
  • From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia · the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland · the University of Chicago Medical Center, Chicago (G.F.F.) · the University of Calgary, Calgary, AB, Canada (B.A.W.) · the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy · the National Institute of Oncology, Budapest, Hungary (I.L.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.) · University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain · the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston · Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.) · the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.) · Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.) · Mayo Clinic, Rochester, MN (M.P.G., J.N.I.) · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.) · Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.) · Weston Park Hospital, Sheffield, United Kingdom (R.C.) · and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.). · Pubmed 29863451
2014
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy, · Pubmed 25007961
2013
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy. · Pubmed 23915740
  • Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 23871531
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 23725877
  • Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy. · Pubmed 23491275
  • Division of Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24091127
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 23912960
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Pubmed 23763700
  • Division of Nuclear Medicine, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy. · Pubmed 23748238
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23245877
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23098574
2012
  • European Institute of Oncology, Medical Oncology, Milan, Italy. · Pubmed 22827581
  • Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22520733
  • Medical Senology Research Unit & Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22749924
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22618719
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22399188
  • Medical Senology Research Unit, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22341133
  • Division of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 22228432
  • Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 21468637
2011
  • Division ofSenology, European Institute of Oncology, Milan, Italy. · Pubmed 22015302
  • Division of Senology, European Institute of Oncology, Milano, Italy. · Pubmed 21479691
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22015303
  • Division of Medical Oncology, Department of Medicine, Unit Research of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21822638
  • Medical Senology Research Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21397505
  • Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 21248632
  • Research Unit of Medical Senology at the Department of Medicine, European Institute of Oncology, Milano, Italy. · Pubmed 21221766
  • Research Unit of Medical Senology, European Institute of Oncology, via Ripamonti 435, Milan, Italy. · Pubmed 20638282
2010
  • Research Unit of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 21147693
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 20625816
Probable:    Miscellaneous institutions in Milan      
2018
  • German Breast Group, Neu-Isenburg, Germany. Electronic address: · Divisione di Senologia Medica, Division of Medical Senology, Milan, Italy. · Marienhospital Bottrop, Klinik fur Gynakologie und Geburtshilfe, Bottrop, Germany. · Hospital Universitario Arnau de Vilanova, Lleida, Spain. · Centro de Estudos de Hematologia e Oncologia, Sao Paulo, Brazil. · Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. · Amgen, Thousand Oaks, CA, USA. · Pubmed 29880292
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 90 total) written by Marco Angelo Colleoni about Breast Neoplasms:

  • Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer. 2018
  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. 2018
  • Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial. 2018
  • Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial. 2018
  • Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00. 2018
  • Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer. 2018
  • Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study. 2018
  • Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. 2018
  • The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer. 2018
  • Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. 2018
Show List of Full Article Records
Google Searches

Learn more about Marco Angelo Colleoni using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
European Institute of Oncology
Miscellaneous institutions in Milan
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
European Institute of Oncology
2018
  • Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: · IBCSG Statistical Center and Department of Mathematics and Statistics, University of Vermont, Burlington, VT, USA. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy. · Centro di Riferimento Oncologico, Aviano, Italy. · Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Orsola Hospital and University of Bologna, Bologna, Italy. · Riverina Cancer Care Centre, Wagga Wagga, NSW, Australia. · Breast Center St Gallen, Kantonsspital, St Gallen, Switzerland. · Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · IBCSG and University of Sydney, Sydney, NSW, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · IBCSG and European Institute of Oncology, Milan, Italy. · Pubmed 30196031
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Seoul National University Hospital, Cancer Research Institute, and Seoul National University College of Medicine, Seoul, South Korea. · Division of Medical Senology, Istituto Europeo di Oncologia, Milan, Italy. · Hospital de Caridade de Ijuí, Cacon, Ijuí, Brazil. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Breast Center, Department of Obstetrics and Gynaecology, University of Munich, Munich, Germany. · UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Organisation for Oncology and Translational Research, Hong Kong Special Administrative Region, China. · Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea. · Research Institute and Hospital, National Cancer Center, Goyang, South Korea. · Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico. · Institut Català d'Oncologia, Hospital Moisès Broggi, Barcelona, Spain. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · HCG Curie Centre of Oncology and Kidwai Memorial Institute of Oncology, Bangalore, India. · University of Ottawa, Ottawa, ON, Canada. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Breast Unit, Kliniken Essen-Mitte, Essen, Germany. · American University of Beirut Medical Center, Beirut, Lebanon. · Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan. · Novartis, East Hanover, NJ, USA. · Novartis, Basel, Switzerland. · National Taiwan University Hospital, Taipei, Taiwan. Electronic address: · Pubmed 29804902
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, and Harvard T.H Chan School of Public Health, Boston, MA, USA. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, Department of Oncology and Hemato-oncology, European Institute of Oncology and University of Milan, Milan, Italy. · National Institute of Oncology, Budapest, Hungary. · Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Rimini, Dipartimento di Oncologia ed Ematologia, AUSL della Romagna, Rimini, Italy. · Translational Research Coordination and Central Pathology Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan and International Breast Cancer Study Group Central Pathology Office, Milan, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, and International Breast Cancer Study Group, Prato, Italy. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School and Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Scientific & Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, and International Breast Cancer Study Group, Milan, Italy. · Pubmed 29589138
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy. · Data Management, Clinical Trial Office, Scientific Direction, European Institute of Oncology, Milan, Italy. · Scientific and Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Pubmed 29486983
  • Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. Electronic address: · IRCCS Arcispedale S Maria Nuova Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Italy. · European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy. · SSD Medical Oncology Addari, Policlinico Sant'Orsola Malpighi, Bologna, Italy. · Department of Oncology, Azienda Sanitaria Universitaria Integrata, Udine, Italy. · Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. · Oncology, Azienda Ospedaliero Universitaria di Ferrara-Arcispedale Sant'Anna, Ferrara, Italy. · Fondazione Michelangelo, Milan, Italy. · Pubmed 29326029
  • International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia. · International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland. · International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium. · International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. · International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary. · International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium. · International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy. · Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark. · Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · German Breast Group, Neu-Isenburg, Germany. · SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain. · Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. · Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria. · Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile. · Cancer Trials Ireland and Cork University Hospital, Cork, Ireland. · International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy. · Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium. · Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland. · Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy. · International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy. · Pubmed 29158011
  • Post-graduation school in Radiodiagnostics, University of Milan, Milan, Italy. · Department of Radiological Science and Radiation Therapy, European Institute of Oncology (IEO), Milan, Italy. · Division of Medical Senology, European Institute of Oncology (IEO), Milan, Italy. · Department of Oncology, University of Milan, Milan, Italy. · Pubmed 30312335
  • Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Radiotherapy, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Plastic and Reconstructive Surgery, IRCCS Policlinico San Donato, piazza Edmondo Malan 1, San Donato Milanese, 20097, Milan, Italy. · Pubmed 29759643
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Pathology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Endoscopy, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 28778379
2017
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 28093280
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Biobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Biobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy; University of Milan, School of Medicine, Italy. Electronic address: · Pubmed 28544923
  • Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School · Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute · Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation · Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation · Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA · Signe Borgquist, Lund University, Lund, Sweden · Thomas P. Ahern, University of Vermont, Burlington, VT · Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy · István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary · Marc Debled, Institut Bergonié, Bordeaux, France · Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark · Roger von Moos, Cantonal Hospital Graubuenden, Chur · Swiss Group for Clinical Cancer Research and IBCSG · Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern · Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen · Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland · Ian Smith, The Royal Marsden Hospital, London, United Kingdom · and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia. · Pubmed 28380313
  • Division of Medical Senology, European Institute of Oncology, 20141 Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, 20141 Milan, Italy. · Division of Early Drugs Development, European Institute of Oncology, 20141 Milan, Italy. · Palliative Care, Sassari, Italy. · Department of Medicine, European Institute of Oncology, 20141 Milan, Italy. · Division of Medical Senology, European Institute of Oncology, 20141 Milan, Italy. Electronic address: · Pubmed 28131905
  • Poornima Saha and Gini F. Fleming, The University of Chicago Medical Center, Chicago, IL · Meredith M. Regan, Weixiu Luo, Harold J. Burstein, and Richard D. Gelber, Dana-Farber Cancer Institute · Meredith M. Regan, Harold J. Burstein, and Richard D. Gelber, Harvard Medical School · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA · Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello · Karin Ribi and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center · Jürg Bernhard, Bern University Hospital, Inselspital, Bern, Switzerland · Prudence A. Francis, Peter MacCallum Cancer Center · St Vincent's Hospital · University of Melbourne, Melbourne · Josephine Stewart, Austin and Heidelberg Repatriation Medical Center, Heidelberg, Victoria · Prudence A. Francis, Josephine Stewart, and Michelle Nottage, University of Newcastle, Newcastle · Alan S. Coates, University of Sydney, Sydney, New South Wales · Michelle Nottage, Royal Brisbane Hospital, Brisbane, Queensland, Australia · Barbara A. Walley, University of Calgary · National Cancer Institute of Canada, Calgary, Alberta, Canada · Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru · Vani Parmar, Tata Memorial Centre, Mumbai, India · Roberto Torres, Instituto Nacional del Cancer, Santiago de Chile, Chile · Meritxell Bellet, Vall d'Hebron Institute of Oncology · Vall d'Hebron University Hospital · Universitat Autònoma de Barcelona, Barcelona · Antonia Perelló, Hospital Universitari Son Espases, Palma de Mallorca, Spain · Faysal Dane, Marmara University Hospital, Istanbul, Turkey · Antonio Moreira, Instituto Português de Oncologia Francisco Gentil - Centro de Lisboa, Lisbon, Portugal · Daniel Vorobiof, Sandton Oncology Centre, Johannesburg, South Africa · and Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy. · Pubmed 28654365
  • Department of Surgery and Cancer, Imperial College London, London, UK. · Department of Experimental Oncology, European Institute of Oncology Milan, Italy. · Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, IT. · Swammerdam Institute for Life Sciences, University of Amsterdam. · Genomics Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, USA. · Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), Italy. · Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), and Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany. · Division of Pathology, European Institute of Oncology and University of Milan, School of Medicine, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milano, Milan, IT. · Division of Medical Senology, European Institute of Oncology, IEO, Milan, Italy. · Department of Biosciences, University of Milano, Milan, IT. · Pubmed 28112739
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Pubmed 27810700
2016
  • IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA. · Harvard T. H. Chan School of Public Health, Boston, MA, USA. · IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary. · Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 27372069
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Jacquie H. Chirgwin and John F. Forbes, University of Newcastle · John F. Forbes, Calvary Mater Newcastle, Newcastle · Alan S. Coates, University of Sydney School of Public Health, Sydney, New South Wales · Jacquie H. Chirgwin, Box Hill Hospital · Jacquie H. Chirgwin, Maroondah Hospital · Jacquie H. Chirgwin, Monash University, Melbourne, Victoria, Australia · Anita Giobbie-Hurder, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard Medical School, Boston, MA · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergonié, Bordeaux, France · Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy · Ian Smith, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom · Manuela Rabaglio, Inselspital, Bern · Beat Thürlimann, Kantonsspital, St. Gallen, Switzerland · Patrick Neven, University of Leuven · Patrick Neven, University Hospitals Leuven, Leuven, Belgium · István Láng, National Institute of Oncology, Budapest, Hungary. · Pubmed 27217455
  • Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, IL, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4, Dnipropetrovsk, Ukraine. · National Cancer Center, Goyang-si, South Korea. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · NHO Osaka National Hospital, Osaka, Japan. · Istituto Europeo di Oncologia, Milan, Italy. · Center for Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München (LMU), Munich, Germany. · Pfizer, San Diego, CA, USA. · Pfizer, Cambridge, MA, USA. · Pfizer, Collegeville, PA, USA. · Pfizer, New York, NY, USA. · University of California, Los Angeles, Los Angeles, CA, USA. · Pubmed 26947331
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Avenue, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Swiss Group for Clinical Cancer Research SAKK, Lugano Viganello, Switzerland. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Via Ripamonti 435, Milan, 20141, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · IBCSG Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Dana-Farber Cancer Institute, Department of Biostatistics and Computatonal Biology, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, 450 Brookline Avenue, Boston, MA, 02215, USA. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · National Cancer Institute of Canada, Kingston, ON, Canada. · Pubmed 27825388
  • Department of Oncology, Institute of Clinical Sciences, Sahgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: · Department of Mathematics and Statistics, University of Vermont, Burlington, Vermont. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, Massachusetts. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Harvard T. F. Chan School of Public Health, Boston, Massachusetts. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · Senior Consultant Breast Cancer, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · International Breast Cancer Study Group, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Institute of Radiotherapy, Klinik Hirslanden, Zürich, Switzerland. · Pubmed 27598802
  • Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA · Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne · University of Newcastle, Newcastle · Alan S. Coates, University of Sydney, Sydney, Australia · Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland · Gini F. Fleming, University of Chicago Medical Center, Chicago, IL · Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada · Giuseppe Viale, University of Milan · Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan · Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo · Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy · István Láng, National Institute of Oncology, Budapest, Hungary · Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Pubmed 27044936
  • Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan 20141, Italy. Electronic address: · Pubmed 26869050
  • Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Radiotherapy, European Institute of Oncology, Milan, Italy. · Department of Surgery, European Institute of Oncology, Milan, Italy. · Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26842491
  • Marco Colleoni and Aron Goldhirsch, European Institute of Oncology and International Breast Cancer Study Group, Milan · Lorenzo Gianni, Ospedale degli Infermi and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy · Zhuoxin Sun, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center and Frontier Science and Technology Research Foundation · Zhuoxin Sun and Richard D. Gelber, Harvard T.F. Chan School of Public Health · Richard D. Gelber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Per Karlsson, Institute of Selected Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden · John F. Forbes, Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Beat Thürlimann, Breast Center Kantonsspital, St Gallen, and Swiss Group for Clinical Cancer Research · and Monica Castiglione, International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 26786933
2015
  • Division of Medical Senology and International Breast Cancer Study Group, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 26241939
  • Division of Medical Senology, and International Breast Cancer Study Group, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy, · Pubmed 26177891
  • International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Dana-Farber Cancer Institute and Alliance for Clinical Trials in Oncology, Boston, MA, USA. · Medical Oncology, Osp Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo, Italy. · Medical Oncology, Ospedale di Circolo and Fondazione Macchi, and International Breast Cancer Study Group, Varese, Italy. · Medical Oncology, Centro di Riferimento Oncologico, and International Breast Cancer Study Group, Aviano, Italy. · Breast Center, Kantonsspital St Gallen, Swiss Group for Clinical Cancer Research (SAKK), and International Breast Cancer Study Group, St Gallen, Switzerland. · Department of Oncology, University Hospital of Udine, University of Udine and International Breast Cancer Study Group, Udine, Italy. · Oncology Unit, Salvatore Maugeri Foundation, and International Breast Cancer Study Group, Pavia, Italy. · Surgical Oncology, Breast Services, Tata Memorial Hospital, and International Breast Cancer Study Group, Mumbai, India. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, Lugano Viganello, Switzerland. · University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne and Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia, and International Breast Cancer Study Group. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Program for Breast Health (Senology), European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland. · Tom Baker Cancer Centre and National Cancer Institute of Canada Clinical Trials Group, Calgary, AB, Canada. · Pubmed 26092816
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, and Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · University of Milan School of Medicine, Milan, Italy; Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 25933934
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26362840
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Quantitative Methods and Statistics, University of Milan-Bicocca, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 26255932
  • Division of Medical Senology, European Institute of Oncology, Italy; International Breast Cancer Study Group, Italy. Electronic address: · Division of Medical Senology, European Institute of Oncology, Italy. · Pubmed 26249119
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Karen N. Price, Frontier Science and Technology Research, Boston, MA · Elizabeth Mallon, Southern General Hospital · Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom · Giuseppe Viale, European Institute of Oncology and University of Milan · Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy · Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergoniié, Bordeaux, France · and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
2014
  • International Breast Cancer Study Group; European Institute of Oncology, Milan, Italy. · Pubmed 24516011
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 24998489
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Scientific Direction, European Institute of Oncology, Milan, Italy. · Pubmed 24742826
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. Electronic address: · Pubmed 24709436
  • International Breast Cancer Study Group and Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. Electronic address: · International Breast Cancer Study Group and Breast Health Program, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 24360786
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, Unit of Biostatistics, Epidemiology and Public Health, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Italy. · School of Medicine, University of Milan, Italy; Molecular Senology Unit, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Vice-Scientific Director, European Institute of Oncology, Milan, Italy. · Pubmed 24325948
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Italy. · Integrated Breast Surgery Unit, European Institute of Oncology and University of Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 24183613
2013
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24074780
  • Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. Electronic address: · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA. · Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Department of Medical and Biological Sciences, Medical Oncology, University of Udine, Udine, Italy. · Quality of Life Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Institute of Oncology, Budapest, Hungary. · Department of Oncology, Ospedale Infermi Rimini and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy. · Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. · Medical Oncology, Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Medical Oncology, Spital STS AG, Thun, Switzerland. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Unité de Onco-Gynécologie médicale, Departement de Médecine Hôpitaux, Universitaires de Genève, Genève, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Department of Medical Oncology, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23453899
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 23633450
2011
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22015285
  • European Institute of Oncology, Milan, Italy. · Pubmed 21321298
2018
  • From the Institute of Cancer Research and Royal Marsden Hospital, London (N.C.T.) · David Geffen School of Medicine at University of California, Los Angeles, Santa Monica (D.J.S.), and Pfizer Oncology, San Diego (X.H.) - both in California · National Cancer Center, Goyang-si, Gyeonggi-do (J.R.), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul (S.-A.I.) - both in South Korea · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital 4, Dnipropetrovsk, Ukraine (I.B.) · National Hospital Organization Osaka National Hospital, Osaka (N.M.), and Aichi Cancer Center Hospital, Nagoya (H.I.) - both in Japan · Istituto Europeo di Oncologia (M. Colleoni) and Pfizer Oncology (C.G.) - both in Milan · Abramson Cancer Center, University of Pennsylvania, Philadelphia (A.D.), and Pfizer Oncology, Collegeville (C.H.B.) - both in Pennsylvania · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi) · Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada (S.V.) · Brustzentrum der Universität München, Munich (N.H.), and the German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany · Institut Gustave Roussy, Villejuif, France (F.A.) · Pfizer Oncology, Cambridge, MA (K.P.T.) · and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago (M. Cristofanilli). · Pubmed 30345905
  • From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia · the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland · the University of Chicago Medical Center, Chicago (G.F.F.) · the University of Calgary, Calgary, AB, Canada (B.A.W.) · the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy · the National Institute of Oncology, Budapest, Hungary (I.L.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.) · University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain · the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston · Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.) · the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.) · Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.) · Mayo Clinic, Rochester, MN (M.P.G., J.N.I.) · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.) · Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.) · Weston Park Hospital, Sheffield, United Kingdom (R.C.) · and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.). · Pubmed 29863451
2014
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy, · Pubmed 25007961
2013
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy. · Pubmed 23915740
  • Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 23871531
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 23725877
  • Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy. · Pubmed 23491275
  • Division of Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24091127
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 23912960
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Pubmed 23763700
  • Division of Nuclear Medicine, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy. · Pubmed 23748238
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23245877
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23098574
2012
  • European Institute of Oncology, Medical Oncology, Milan, Italy. · Pubmed 22827581
  • Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22520733
  • Medical Senology Research Unit & Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22749924
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22618719
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22399188
  • Medical Senology Research Unit, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22341133
  • Division of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 22228432
  • Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 21468637
2011
  • Division ofSenology, European Institute of Oncology, Milan, Italy. · Pubmed 22015302
  • Division of Senology, European Institute of Oncology, Milano, Italy. · Pubmed 21479691
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22015303
  • Division of Medical Oncology, Department of Medicine, Unit Research of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21822638
  • Medical Senology Research Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21397505
  • Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 21248632
  • Research Unit of Medical Senology at the Department of Medicine, European Institute of Oncology, Milano, Italy. · Pubmed 21221766
  • Research Unit of Medical Senology, European Institute of Oncology, via Ripamonti 435, Milan, Italy. · Pubmed 20638282
2010
  • Research Unit of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 21147693
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 20625816
Miscellaneous institutions in Milan
2018
  • German Breast Group, Neu-Isenburg, Germany. Electronic address: · Divisione di Senologia Medica, Division of Medical Senology, Milan, Italy. · Marienhospital Bottrop, Klinik fur Gynakologie und Geburtshilfe, Bottrop, Germany. · Hospital Universitario Arnau de Vilanova, Lleida, Spain. · Centro de Estudos de Hematologia e Oncologia, Sao Paulo, Brazil. · Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. · Amgen, Thousand Oaks, CA, USA. · Pubmed 29880292
Unspecified
2016
  • Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology · Giuseppe Viale, University of Milan, Milan · Lorenzo Gianni, Ospedale degli Infermi, Rimini · Fabio Puglisi, University Hospital of Udine, University of Udine, Udine · Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo · Katia Cagossi, Ospedale di Carpi, Carpi, Italy · Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center · Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute · Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA · István Láng, National Institute of Oncology, Budapest, Hungary · Beat Thürlimann, Kantonsspital, St Gallen · Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern · Elena Kralidis, Kantonsspital Aarau, Aarau · Daniel Rauch, Spital Thun, Thun, Switzerland · Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland · Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group · Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria · Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia · Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru · Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden · and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Pubmed 27325862
2016
  • Karin Ribi, Aron Goldhirsch, and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center · Jürg Bernhard, Bern University Hospital, Inselspital, Bern · Thomas Ruhstaller, Breast Center St Gallen, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, St Gallen, Switzerland · Weixiu Luo, Karen N. Price, Richard D. Gelber, and Meredith M. Regan, International Breast Cancer Study Group Statistical Center · Weixiu Luo, Harold J. Burstein, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute · Harold J. Burstein, Alliance for Clinical Trials in Oncology · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber and Meredith M. Regan, Harvard Medical School, Boston, MA · Gini F. Fleming, The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL · Prudence A. Francis, International Breast Cancer Study Group, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria · Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Eva Ciruelos, University Hospital 12 de Octubre and SOLTI Group, Madrid · Meritxell Bellet, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, and SOLTI Group, Universitat Autònoma de Barcelona, Barcelona · Ana Lluch, Hospital Clinico Universitario de Valencia, Incliva Biomedical Research Institute, University of Valencia and SOLTI Group, Valencia · Antonia Perelló, Hospital Universitari Son Espases and SOLTI Group, Palma de Mallorca, Spain · Lorenzo Pavesi, Salvatore Maugeri Foundation and International Breast Cancer Study Group, Pavia · Marilena Visini, Ospedale Civile di Lecco and International Breast Cancer Study Group, Lecco · Carlo Tondini, Ospedale Papa Giovanni XXIII and International Brea · Pubmed 27022111
2015
2014
40 Other Locations Show
Yearly article counts 0127121110151011200
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.